Is it time to re-evaluate the treatment of pemphigus?
Leventhal JS, Sanchez MR. Is it time to re-evaluate the treatment of pemphigus? Journal Of Drugs In Dermatology 2012, 11: 1200-6. PMID: 23134985.Peer-Reviewed Original ResearchConceptsIntravenous immunoglobulinCorticosteroid-related adverse effectsAdverse effectsTreatment of pemphigusCost of therapySerious adverse effectsManagement of pemphigusBest practice treatmentSystemic corticosteroidsClinical improvementMost patientsMucocutaneous diseaseStandard therapyBiologic agentsImmunosuppressive agentsPemphigus vulgarisBody of evidenceRecent trialsFatal infectionNovel therapiesTherapeutic strategiesPemphigusTherapyRemissionTreatment